APA (7th ed.) Citation

S, F., PW, B., DL, K., PD, M., C, R., AT, W., . . . EM, L. (2019). Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment. The Journal of clinical endocrinology and metabolism, 104(8), 3450. https://doi.org/10.1210/jc.2019-00271

Chicago Style (17th ed.) Citation

S, Ferrari, Butler PW, Kendler DL, Miller PD, Roux C, Wang AT, Huang S, Wagman RB, and Lewiecki EM. "Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment." The Journal of Clinical Endocrinology and Metabolism 104, no. 8 (2019): 3450. https://doi.org/10.1210/jc.2019-00271.

MLA (9th ed.) Citation

S, Ferrari, et al. "Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment." The Journal of Clinical Endocrinology and Metabolism, vol. 104, no. 8, 2019, p. 3450, https://doi.org/10.1210/jc.2019-00271.